Delivery Order SPE2DB20D3103-SPE2DB21FL5Z9
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,463.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that spans through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies, including...
- The Defense Logistics Agency (DLA) awarded a $6,794.43 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide prime vendor pharmaceutical products and medical supplies. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of a variety of medical products and supplies. The $3,441.88 firm fixed-price contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,714.50 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 9, 2025. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,534.80 delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a prime vendor pharmaceutical supply solution. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., to supply a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $157,682.91 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price and runs through November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $23,612.50 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through March 2025, is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,714.71 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The $1,090.92 delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver essential medications, vaccines, syringes, and other critical medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FL5Z9Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a prime vendor pharmaceutical distribution service for the DLA Troop Support Medical. The contract, valued at $1,745.73, is a firm fixed-price delivery order with no set-aside designation, indicating open competition. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, which runs through November 2026. The IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices, to support military healthcare programs globally. Additionally, AmerisourceBergen holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/18/20 |